Module 4.1 (Geriatrics) Flashcards

1
Q

What are geriatric syndromes?

A

“Multifactorial health conditions that occur when the accumulated effects of impairments in multiple systems render person vulnerable to situational challenges”

>The result of a series of processes or changes, suggesting multiple contributors

>Management does not always depend on the underlying cause/s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some common geriatric syndromes?

A

Incontinence ◼ Insomnia ◼ Delirium ◼ Dementia

Falls ◼ Osteoporosis ◼ Weight loss/ sarcopenia (loss of muscle tissue) ◼ Poor vision

Frailty: A biologic syndrome of decreased reserve and resistance to stressors, resulting from cumulative declines across multiple physiologic systems, and causing vulnerability to adverse outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some physiological changes in the elderly?

A

Increased Gastric pH → slightly decreased absorption

Delayed gastric emptying

Reduced splanchnic blood flow

Decreased absorption surface

Decreased gastrointestinal motility

Increased body fat → increased volume of distribution and t½ of lipophilic drugs

Decreased lean body mass

Decrease total body water

Decreased serum albumin

Increase a1-acid glycoprotein

Decreased hepatic blood flow

Decreased hepatic mass

Decreased renal blood flow and glomerular filtration rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some pharmacodynamic changes with aging?

A

In older people, the effects of similar drug concentrations at the site of action may be greater or smaller than those in younger people

Several causes:

>altered receptor expresison

>reduces organ mass

>changed tissue response

Influences the likelihood of desirable and undesirable responses to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Impact of falls on the elderly?

A

An event which results in a person coming to rest inadvertently on the ground or floor or other lower level

>A leading cause of death and disability for those >65

>Each year

30% – 40% of people in the community fall ◼ 50% of residential care residents fall

>For 20-30% this leads to loss of mobility, independence and risk of premature death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is impacted when an elderly person falls?

A

40% = hip and pelvis

17% = wrist and foreram

8% = shoulder

6% = spine

5% = ankle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the outcomes of hip fractures in the elderly?

A

53% = transfer to other health service, a transitional care/rehab facility

30%= discharge to usual residence

11%= discharge to residential care

6%= death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the factors that can contribute to falls?

A

Physiological: weakness and frailty

Cardiovascular: syncope, postural hypotension, hypotension

Neurological: epilepsy/seizures, parkinson’s disease, peripheral neuropathy, dementia, drowsiness/sedation

Mechanical: inappropriate use of aids and footwear

Ophthalmological: cataracts, macular degeneration, glaucoma, blurred vision

Environmental: lighting, rugs, stairs/steps

Muscoskeletal: arthritis and deconditioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outline what medications can cause the following falls risk:

A) blurred vision

B) confusion

C) agitiation

D) balance

A

A)

◼ Eye drops ◼ Anticholinergics ◼ Medications with anticholinergic effects

B)

Benzodiazepines ◼ Narcotics ◼ Psychotropics ◼ Any medicine with anticholinergic effects

C)

Antidepressants ◼ Caffeine ◼ Antipsychotics ◼ Stimulants

D)

Anticonvulsants ◼ Benzodiazepines ◼ Antipsychotics ◼ Prochlorperazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline what medications can cause the following falls risk:

A) syncope

B) gait abnormalities

C) dizziness/hypotension

D) urinary urgency

A

A)

Blood pressure medicines

Vasodilators

B)

Antidepressants

Antipsychotics

Anti-nauseants

Anti-epilipetics

Benzodiazepines

C)

Antihypertensives

Diuretics

Medications with anticholinergic effects

D)

Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some age related vision conditions?

A

Glaucoma → causes tunnel vision

Cataracts → lazy effect

Macular degeneration → central part of vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is glaucoma? What causes it?

A

Slowly progressive, insidious onset optic nerve damage leading to reduced vision

Typically due to increased intraocular pressue (IOP)

>mechanisms of pressure damage to nerve

>low tension glaucoma also possible

Classified by cause of increased IOP

>open angle

>closed angle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the clinical presentation for the following types of glaucoma:

A) open angle

B) acute closed angle-often symptomatic

C) chronic closed angle

A

A)

few symptoms until visual field loss, then disease is quite advanced

B)

severe pain, headache, sudden blurring of vision, intra-ocular pressure often >50mmHg

C)

Chronic closed angle

>fewer symptoms than acute angle closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to manage open angle glaucoma?

A

Prostaglandin analogues (bimatoprost, latanoprost, tafluprost, travoprost) → 1 doses a day → first line, increase aqueous outflow, most effective class, may cause iris hyperpigmentation and eyelash changes

Beta-blockers (betaxolol, timolol) → 1-2 doses per day → first line, decrease aqueous production, may cause systemic adverse effects e.g. bradycardia, generally avoided in severe or poorly controlled asthma

Alpha2 agonists (apraclonidine, briomonidine ) → 2-3 doses per day → second line, increase aqueous outflow and decrease its production, apraclonidine

Carbonic anhydrase inhibitors (brinzolamide, dorzolamide) → 2-3 doses per day → second line, decrease aqueous production

Cholinergic (pilocarpine 3-4 doses per day) → rarely used (angle closure glaucomas and some secondary glaucomas, seek specialist advice). Increases aqueous outflow, high incidence of adverse effects such as blurred vision and headache.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is cataracts? What is the cause?

A

A cataract is any opacity in the lens

>Ageing most common cause; pathogenesis not well understood

→ protein aggregates scatter light rays and reduce lens transparency

>Other factors can be involved, e.g. trauma, toxins, systemic disease (e.g. diabetes), smoking, heredity

>Also associated with long term administration of corticosteroids (systemic or topical), some phenothiazines, amiodarone (amiodraone causes opacity of the lens)

>Age-related cataracts common cause of visual impairment. 50% aged 65–74; 70% for those over 75

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to manage cataracts?

A

Surgical replacement of clouded lens with intraocular lenses (IOL)

Postoperative therapy may involve short regimens of combinations of topical antibiotics (e.g. chloramphenicol) and NSAIDS (e.g ketorolac) and/or corticosteroids (e.g fluoromethalone)

>protocols may vary amongst individual specialists

17
Q

What is the macula?

A

The central, posterior portion of the retina containing the densest concentration of photoreceptors within the retina

◼ Responsible for central high-resolution visual acuity, allowing a person to see fine detail, read, and recognise faces

18
Q

What happens with age to the macula?

A

◼ With age, focal depositions of acellular, polymorphous debris occurs within the retina, called drusen

>Excess drusen leads to damage to the retina and destruction of the macula

19
Q

From the previous questions, what is macular degeneration (AMD)

→ age related macular degeneration

A

AMD may occur with the development of a choroidal neovascular membrane (‘wet AMD’) or due to retinal atrophy (‘dry MD’)

20
Q

How to treat dry AMD?

A

Smoking cessation

Moderate to severe AMD- antioxidant vitamins and zinc (eg, Ocuvite PreserVision).

>Doses should be consistent with the Age-Related Eye Disease Study 2 (AREDS2) formulation

21
Q

What is the the treatment of wet AMD (new blood vessels inappropriately forming in the macula)

A

Primary therapy is intravitreal antiangiogenic therapy

>Ranibizumab Lucentis® >Bevacizumab Avastin® >Anecortave Retaane® >Verteporfin Visudyne®

22
Q

What is delirium?

>dementia patients at risk of developing this

A

Acute transient, usually reversible, fluctuating disturbance in attention, cognition and consciousness level

Hallmarks are decreased attention span and a waxing and waning type of confusion

23
Q

What are some precipitants of delirium?

A

Disease

Metabolic Disorder

Carcinoma

Infection

Neurological Disorder

Inflammation

Pain

Dehydration

Constipation

Malnutrition

Urinary retention/UTI

Sensory impairment

Drug effects (and interactions)

Drug/alcohol withdrawal syndromes

Lack of stimulation

Surgery

24
Q

What are the risk factors for delirium?

A

Pre-existing dementia or brain injury

Frail elderly- the older the more susceptible

Comorbidity

Polypharmacy

Changes in medication

>when a new drug is started

>when a dose is changed

>when another drug is added, stopped or changed

>when a drug is stooped

  • treated condition can get worse
  • withdrawal side effects e.g. BZD, antidepressantsd
25
Q

What are the commonly implicated drug groups in delirium?

A

Anticholinergics ◼

Benzodiazepines ◼

Opioids (including pethidine and tramadol) ◼

Corticosteroids ◼

Nonsteroidal anti-inflammatory drugs ◼

Dopaminergic drugs (eg levodopa, dopamine agonists, catechol-o-methyltransferase [COMT] inhibitors) ◼

Sotalol and propranolol (unlikely with other beta blockers) ◼

Alcohol and illicit drugs (eg cannabis, methamphetamine).

26
Q

Delirium management?

A

Up to a third of delirium episodes in hospitalised elderly patients can be prevented using nonpharmacological approaches

The key principle in management is to identify and treat the underlying cause, relying primarily on nonpharmacological measures

>Pharmacological management is unnecessary for most delirious patients

>Antipsychotic treatment is sometimes required to control anxiety, agitation, aggression, delusions and/or hallucinations

→ a single dose is usually adequate → haloperidol worsens outcomes for people with delirium → use carefully

27
Q

How to do good prescribing in older people?

A
  • Carry out a regular medication review and discuss and agree all changes with the patient
  • Stop any current drugs that are not indicated
  • Prescribe new drugs that have a clear indication
  • If possible, avoid drugs that have known deleterious effects in elderly patients, such as benzodiazepines, and recommend dosage reduction when appropriate
  • Use the recommended dosages for elderly patients
  • Use simple drug regimens and appropriate administration systems
  • Consider using once daily or once weekly formulations and using fixed dose combinations when possible
  • Consider non-pharmacological treatments if appropriate
  • Limit the number of people prescribing for each patient if possible
  • Where possible, avoid treating adverse drug reactions with further drugs
  • Regular appropriate monitoring becomes of utmost importance when using medications in older people
  • Predicting the effects of medications becomes more difficult in older people → pharmacokinetics and pharmacodynamics become more complicated with age, comorbidity and polypharmacy
28
Q

Case Study-MA

A

Consider antiresorptive treatment and calcium supplementation

Reduce the dose of ISMN

Cease clopidogrel

Consider antiresorptive treatment and calcium supplementation

Minimise medications that may influence falls or injury

>No history of angina since admission to facility four years ago

>Is not prescribed PRN GTN

>Coronary arteries were stented over 15 years ago

→ Regular appropriate monitoring becomes of utmost importance when using medications in older people

29
Q

What are the risk factors for delirium?

A

Pre-existing dementia or brain injury

Frail elderly- the older the more susceptible

Comorbidity

Polypharmacy

Changes in medication

>when a new drug is started

>when a dose is changed

>when another drug is added, stopped or changed

>when a drug is stooped

  • treated condition can get worse
  • withdrawal side effects e.g. BZD, antidepressantsd
30
Q

How to manage cataracts?

A

Surgical replacement of clouded lens with intraocular lenses (IOL)

Postoperative therapy may involve short regimens of combinations of topical antibiotics (e.g. chloramphenicol) and NSAIDS (e.g ketorolac) and/or corticosteroids (e.g fluoromethalone)

>protocols may vary amongst individual specialists

31
Q

What are some physiological changes in the elderly?

A

Increased Gastric pH → slightly decreased absorption

Delayed gastric emptying

Reduced splanchnic blood flow

Decreased absorption surface

Decreased gastrointestinal motility

Increased body fat → increased volume of distribution and t½ of lipophilic drugs

Decreased lean body mass

Decrease total body water

Decreased serum albumin

Increase a1-acid glycoprotein

Decreased hepatic blood flow

Decreased hepatic mass

Decreased renal blood flow and glomerular filtration rate